Type, topography, and sequelae of neuropathological changes shaping clinical phenotype of autism

Autism: Oxidative Stress, Inflammation, and Immune Abnormalities

Volumn , Issue , 2009, Pages 1-34

  Wegiel, Jerzy ^a   Wisniewski, Thomas ^b   Chauhan, Abha ^a   Chauhan, Ved ^a   Kuchna, Izabela ^a   Nowicki, Krzysztof ^a   Imaki, Humi ^a   Wegiel, Jarek ^a   Ma, Shuang Yong ^a   Bobrowicz, Teresa Wierzba ^c   Cohen, Ira L ^a   London, Eric ^a   Ted Brown, W ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b Aging and Dementia Research Center   (United States)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650509759     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (273)

1. Aitken, A. R. and I. Tork (1988). Early development of serotonin-containing neurons and pathways as seen in wholemount preparations of the fetal rat brain. J. Comp. Neurol. 274:32-47.
2. Akyol, O., H. Herken, E. Uz, E. Fadillioglu, S. Unal, S. Sogut, H. Ozyurt, and H. A. Savas (2002). The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: The possible role of oxidant/antioxidant imbalance. Prog. Neuropsychopharmacol. Biol. Psychiatry 26:995-1005.
3. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. American Psychiatric Association, Washington, DC.
4. Arin, D. M., M. L. Bauman, and T. L. Kemper (1991). The distribution of Purkinje cell loss in the cerebellum in autism. Neurology 41 (suppl.): 307.
5. Armstrong, D. D. (2005). Epilepsy-induced microarchitectural changes in the brain. Pediatr. Dev. Pathol. 8:607-614.
6. Aylward, E. H., N. J. Minshew, K. Field, B. F. Sparks, and N. Singh (2002). Effects of age on brain volume and head circumference in autism. Neurology 59:175-183.
7. Aylward, E. H., N. J. Minshew, G. Goldstein, N. A. Honeycutt, A. M. Augustine, K. O. Yates, P. E. Barta, and G. D. Pearlson (1999). MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 53:2145-2150.
8. Bailey, A., C. A. Le, I. Gottesman, P. Bolton, E. Simonoff, E. Yuzda, and M. Rutter (1995). Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol. Med. 25:63-77.
9. Bailey, A., P. Luthert, P. Bolton, C. A. Le, M. Rutter, and B. Harding (1993). Autism and megalencephaly. Lancet 341:1225-1226.
10. Bailey, A., P. Luthert, A. Dean, B. Harding, I. Janota, M. Montgomery, M. Rutter, and P. Lantos (1998). A clinicopathological study of autism. Brain 121(Pt 5):889-905.
11. Bailey, A. R., B. N. Giunta, D. Obregon, W. V. Nikolic, J. Tian, C. D. Sanberg, D. T. Sutton, and J. Tan (2008). Peripheral biomarkers in autism: Secreted amyloid precursor proteinalpha as a probable key player in early diagnosis. Int. J Clin. Exp. Med. 1:338-344.
12. Bale, T. L., A. M. Davis, A. P. Auger, D. M. Dorsa, and M. M. McCarthy (2001). CNS region-specific oxytocin receptor expression: Importance in regulation of anxiety and sex behavior. J. Neurosci. 21:2546-2552.
13. Barden, N. (2004). Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J. Psychiatry Neurosci. 29:185-193.
14. Barkovich, A. J., R. I. Kuzniecky, G. D. Jackson, R. Guerrini, and W. B. Dobyns (2005). A developmental and genetic classification for malformations of cortical development. Neurology 65:1873-1887.
15. Baron-Cohen, S. (2004). The cognitive neuroscience of autism. J. Neurol. Neurosurg. Psychiatry 75:945-948.
16. Baron-Cohen, S., H. Ring, J. Moriarty, B. Schmitz, D. Costa, and P. Ell (1994). Recognition of mental state terms. Clinical findings in children with autism and a functional neuroimaging study of normal adults. Br. J. Psychiatry 165:640-649.
17. Baron-Cohen, S., H. A. Ring, S. Wheelwright, E. T. Bullmore, M. J. Brammer, A. Simmons, and S. C. Williams (1999). Social intelligence in the normal and autistic brain: An fMRI study. Eur. J. Neurosci. 11:1891-1898.
18. Bauman, M. L., P. A. Filipek, and T. L. Kemper (1997). Early infantile autism. Int. Rev. Neurobiol. 41:367-386.
19. Bauman, M. L. and T. L. Kemper (1985). Histoanatomic observations of the brain in early infantile autism. Neurology 35:866-867.
20. Bauman, M. L. and T. L. Kemper (1996). Observation on the Purkinje cells in the cerebellar vermis in autism. J. Neuropath. Exp. Neurol. 55:613.
21. Bengzon, J., Z. Kokaia, E. Elmer, A. Nanobashvili, M. Kokaia, and O. Lindvall (1997). Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc. Natl. Acad. Sci. USA 94:10432-10437.
22. Bielsky, I. F., S. B. Hu, K. L. Szegda, H. Westphal, and L. J. Young (2004). Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 29:483-493.
23. Binder, D. K., S. D. Croll, C. M. Gall, and H. E. Scharfman (2001). BDNF and epilepsy: Too much of a good thing? Trends Neurosci. 24:47-53.
24. Boddaert, N., M. Zilbovicius, A. Philipe, L. Robel, M. Bourgeois, C. Barthelemy, D. Seidenwurm, I. Meresse, L. Laurier, I. Desguerre, N. Bahi-Buisson, F. Brunelle, A. Munnich, Y. Samson, M-C. Mouren, and N. Chabane (2009). MRI findings in 77 children with non-syndromic autism. PLOS one (www.plosone.com) 4:4415e.
25. Bolte, S., D. Hubl, S. Feineis-Matthews, D. Prvulovic, T. Dierks, and F. Poustka (2006). Facial affect recognition training in autism: Can we animate the fusiform gyrus? Behav. Neurosci. 120:211-216.
26. Bolton, P., J. Powell, M. Rutter, V. Buckle, J. R. Yates, Y. Ishikawa-Brush, and A. P. Monaco (1995). Autism, mental retardation, multiple exostoses and short stature in a female with 46, X, t(X;8)(p22.13;q22.1). Psychiatr. Genet. 5:51-55.
27. Brown, W. T., T. Wisniewski, I. L. Cohen, E. London, M. Flory, H. Imaki, I. Kuchna, J. Wegiel, S. Y. Ma, K. Nowicki, J. Wang, and J. Wegiel (2008). Neuropathologic changes in chromosome 15 duplication and autism. In 7th Annual International Meeting for Autism Research (IMFAR).
28. Brunk, U. T., C. B. Jones, and R. S. Sohal (1992). A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat. Res. 275:395-403.
29. Brunk, U. T. and A. Terman (2002a). Lipofuscin: Mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 33:611-619.
30. Brunk, U. T. and A. Terman (2002b). The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J Biochem. 269:1996-2002.
31. Bruton, C. J. (1988). The Neuropathology of Temporal Lobe Epilepsy. In Maudsley Monographs. Oxford University Press, New York.
32. Butler, M. G., M. J. Dasouki, X. P. Zhou, Z. Talebizadeh, M. Brown, T. N. Takahashi, J. H. Miles, C. H. Wang, R. Stratton, R. Pilarski, and C. Eng (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 42:318-321.
33. Buxhoeveden, D. P. and M. F. Casanova (2002). The minicolumn and evolution of the brain. Brain Behav. Evol. 60:125-151.
34. Carper, R. A. and E. Courchesne (2005). Localized enlargement of the frontal cortex in early autism. Biol. Psychiatry 57:126-133.
35. Carper, R. A., P. Moses, Z. D. Tigue, and E. Courchesne (2002). Cerebral lobes in autism: Early hyperplasia and abnormal age effects. Neuroimage 16:1038-1051.
36. Casanova, M. F., D. P. Buxhoeveden, A. E. Switala, and E. Roy (2002). Minicolumnar pathology in autism. Neurology 58:428-432.
37. Casanova, M. F., K. van, I, A. E. Switala, H. van Engeland, H. Heinsen, H. W. Steinbusch, P. R. Hof, J. Trippe, J. Stone, and C. Schmitz (2006). Minicolumnar abnormalities in autism. Acta Neuropathol. 112:287-303.
38. Castren, E., H. Thoenen, and D. Lindholm (1995). Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 64:71-80.
39. Champagne, F., J. Diorio, S. Sharma, and M. J. Meaney (2001). Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc. Natl. Acad. Sci. USA 98:12736-12741.
40. Chandana, S. R., M. E. Behen, C. Juhasz, O. Muzik, R. D. Rothermel, T. J. Mangner, P. K. Chakraborty, H. T. Chugani, and D. C. Chugani (2005). Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci. 23:171-182.
41. Chauhan, A., V. Chauhan, W. T. Brown, and I. Cohen (2004). Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sci. 75:2539-2549.
42. Chauhan, A. and V. Chauhan (2006). Oxidative stress in autism. Pathophysiology 13:171-181.
43. Chauhan, A., B. Muthaiyah, M. M. Essa, T. W. Brown, J. Wegiel, and V. Chauhan (2009). Increased lipid peroxidation in cerebellum and temporal cortex in autism. International Meeting for Autism Research, Chicago, IL, May 8, 2009.
44. Chavko, M., N. S. Nadi, and D. O. Keyser (2002). Activation of BDNF mRNA and protein after seizures in hyperbaric oxygen: Implications for sensitization to seizures in re-exposures. Neurochem. Res. 27:1649-1653.
45. Chen, L., K. Hamaguchi, S. Hamada, and N. Okado (1997). Regional differences of serotoninmediated synaptic plasticity in the chicken spinal cord with development and aging. J. Neural Transplant. Plast. 6:41-48.
46. Chow, T. W. and J. L. Cummings (1999). Frontal-subcortical circuits. In B. L. Miller and J. L. Cummings, (eds.), The Human Frontal Lobes: Functions and Disorders. Guilford Press, New York, pp. 3-26.
47. Chugani, D. C., O. Muzik, M. Behen, R. Rothermel, J. J. Janisse, J. Lee, and H. T. Chugani (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45:287-295.
48. Ciesielski, K. T., R. J. Harris, B. L. Hart, and H. F. Pabst (1997). Cerebellar hypoplasia and frontal lobe cognitive deficits in disorders of early childhood. Neuropsychologia 35:643-655.
49. Cohen, I. L. (2007). A neural network model of autism: Implications for theory and treatment. In D. Mareschal, S. Sirois, G. Westerman, and M. H. Johnson (eds.), Neuroconstructivism. Oxford University Press, Oxford.
50. Cohen, I. L., X. Liu, C. Schutz, B. N. White, E. C. Jenkins, W. T. Brown, and J. J. Holden (2003). Association of autism severity with a monoamine oxidase A functional polymorphism. Clin. Genet. 64:190-197.
51. Conner, J. M., J. C. Lauterborn, Q. Yan, C. M. Gall, and S. Varon (1997). Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport. J. Neurosci. 17:2295-2313.
52. Connolly, A. M., M. Chez, E. M. Streif, R. M. Keeling, P. T. Golumbek, J. M. Kwon, J. J. Riviello, R. G. Robinson, R. J. Neuman, and R. M. Deuel (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59:354-363.
53. Cook, E. Jr. H. (1998). Genetics of autism. Mental Retardation Dev. Disabil. Res. Rev. 4:113-120.
54. Coon, H., D. Dunn, J. Lainhart, J. Miller, C. Hamil, A. Battaglia, R. Tancredi, M. F. Leppert, R. Weiss, and W. McMahon (2005). Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am. J. Med. Genet. B Neuropsychiatr. Genet. 135B:42-46.
55. Courchesne, E., D. M. Karns, H. R. Davis, R. Ziccardi, R. A. Carper, Z. D. Tigue, H. J. Hisum, P. Moses, K. Pierce, C. Lord, A. J. Lincoln, S. Pizzo, L. Schreibman, R. H. Haas, N. A. Akshoomoff, R. Y. Courchesne (2001). Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57:245-254.
56. Courchesne, E., R. Carper, and N. Akshoomoff (2003). Evidence of brain overgrowth in the first year of life in autism. JAMA 290:337-344.
57. Courchesne, E., J. R. Hesselink, T. L. Jernigan, and R. Yeung-Courchesne (1987). Abnormal neuroanatomy in a nonretarded person with autism. Unusual findings with magnetic resonance imaging. Arch. Neurol. 44:335-341.
58. Courchesne, E., C. M. Karns, H. R. Davis, R. Ziccardi, R. A. Carper, Z. D. Tigue, H. J. Chisum, P. Moses, K. Pierce, C. Lord, A. J. Lincoln, S. Pizzo, L. Schreibman, R. H. Haas, N. A. Akshoomoff, and R. Y. Courchesne, E., R. Yeung-Courchesne, G. A. Press, J. R. Hesselink, and T. L. Jernigan (1988). Hypoplasia of cerebellar vermal lobules VI and VII in autism. N. Engl. J. Med. 318:1349-1354.
59. Courchesne, E. and K. Pierce (2005a). Why the frontal cortex in autism might be talking only to itself: Local over-connectivity but long-distance disconnection. Curr. Opin. Neurobiol. 15:225-230.
60. Courchesne, E. and K. Pierce (2005b). Brain overgrowth in autism during a critical time in development: Implications for frontal pyramidal neuron and interneuron development and connectivity. Int. J. Dev. Neurosci. 23:153-170.
61. Dalton, K. M., B. M. Nacewicz, T. Johnstone, H. S. Schaefer, M. A. Gernsbacher, H. H. Goldsmith, A. L. Alexander, and R. J. Davidson (2005). Gaze fixation and the neural circuitry of face processing in autism. Nat. Neurosci. 8:519-526.
62. Dam, A. M. (1980). Epilepsy and neuron loss in the hippocampus. Epilepsia 21:617-629.
63. Damasio, H., R. G. Maurer, A. R. Damasio, and H. C. Chui (1980). Computerized tomographic scan findings in patients with autistic behavior. Arch. Neurol. 37:504-510.
64. Davidovitch, M., B. Patterson, and P. Gartside (1996). Head circumference measurements in children with autism. J. Child Neurol. 11:389-393.
65. Dawson, G., J. Munson, S. J. Webb, T. Nalty, R. Abbott, and K. Toth (2007). Rate of head growth decelerates and symptoms worsen in the second year of life in autism. Biol. Psychiatry 61:458-464.
66. Dementieva, Y. A., D. D. Vance, S. L. Donnelly, L. A. Elston, C. M. Wolpert, S. A. Ravan, G. R. DeLong, R. K. Abramson, H. H. Wright, and M. L. Cuccaro (2005). Accelerated head growth in early development of individuals with autism. Pediatr. Neurol. 32:102-108.
67. Department of Health and Human Services, Centers for Disease Control and Prevention (2007). Morbidity and Mortality Weekly Report 56:1-28.
68. Dissanayake, C., Q. M. Bui, R. Huggins, and D. Z. Loesch (2006). Growth in stature and head circumference in high-functioning autism and Asperger disorder during the first 3 years of life. Dev. Psychopathol. 18:381-393.
69. Earnest, M. P., G. E. Thomas, R. A. Eden, and K. F. Hossack (1992). The sudden unexplained death syndrome in epilepsy: Demographic, clinical, and postmortem features. Epilepsia 33:310-316.
70. Ehlert, U., J. Gaab, and M. Heinrichs (2001). Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: The role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 57:141-152.
71. Erden-Inal, M., E. Sunal, and G. Kanbak (2002). Age-related changes in the glutathione redox system. Cell Biochem. Funct. 20:61-66.
72. Ericksson, P. S., E. Perfilieva, T. Bjork-Eriksson, A. M. Alborn, C. Nordborg, D. A. Peterson, and F. H. Gage (1998). Neurogenesis in the adult human hippocampus. Nat. Med. 4:1313-1317.
73. Evans, T., S. L. Siedlak, L. Lu, X. Fu, Z. Wang, W. R. McGinnis, E. Fakhoury, R. J. Castellani, S. L. Hazen, W. L. Walsh, A. T. Levis, R. G. Salomon, M. A. Smith, G. Perry, and X. Zhu (2008). The autistic phenotype exhibits a remarkably localized modification of brain protein by products of free radical-induced lipid oxidation. Am J Biochem. Biotechnol., Special Issue on Autism Spectrum Disorders 4:61-72.
74. Fairhall, S. L. and A. Ishai (2007). Effective connectivity within the distributed cortical network for face perception. Cereb. Cortex 17:2400-2406.
75. Fehlow, P., K. Bernstein, A. Tennstedt, and F. Walther (1993). Early infantile autism and excessive aerophagy with symptomatic megacolon and ileus in a case of Ehlers-Danlos syndrome. Padiatr. Grenzgeb. 31:259-267.
76. Ferguson, J. N., L. J. Young, E. F. Hearn, M. M. Matzuk, T. R. Insel, and J. T. Winslow (2000). Social amnesia in mice lacking the oxytocin gene. Nat. Genet. 25:284-288.
77. Fidler, D. J., J. N. Bailey, and S. L. Smalley (2000). Macrocephaly in autism and other pervasive developmental disorders. Dev. Med. Child Neurol. 42:737-740.
78. Filipek, P. A. (1996). Brief report: Neuroimaging in autism: The state of the science 1995. J. Autism Dev. Disord. 26:211-215.
79. Filipek, P. A., P. J. Accardo, G. T. Baranek, E. H. Cook Jr., G. Dawson, B. Gordon, J. S. Gravel, C. P. Johnson, R. J. Kallen, S. E. Levy, N. J. Minshew, S. Ozonoff, B. M. Prizant, I. Rapin, S. J. Rogers, W. L. Stone, S. Teplin, R. F. Tuchman, and F. R. Volkmar (1999). The screening and diagnosis of autistic spectrum disorders. J. Autism Dev. Disord. 29:439-484.
80. Folstein, S. E. and B. Rosen-Sheidley (2001). Genetics of autism: Complex aetiology for a heterogeneous disorder. Nat. Rev. Genet. 2:943-955.
81. Folstein, S. E. and M. L. Rutter (1988). Autism: Familial aggregation and genetic implications. J. Autism Dev. Disord. 18:3-30.
82. Fombonne E. (2003). Epidemiological surveys of autism and other pervasive developmental disorders. J. Autism Dev. Disord. 33:365-382.
83. Fombonne, E., B. Roge, J. Claverie, S. Courty, and J. Fremolle (1999). Microcephaly and macrocephaly in autism. J. Autism Dev. Disord. 29:113-119.
84. Friede, R. L. (1975). Developmental Neuropathology. Springer-Verlag, Berlin.
85. Fuh, J. L. and S. J. Wang (1995). Caudate hemorrhage: Clinical features, neuropsychological assessments and radiological findings. Clin. Neurol. Neurosurg. 97:296-299.
86. Gabreels, B. A., D. F. Swaab, D. P. de Kleijn, N. G. Seidah, J. W. Van de Loo, W. J. Van de Ven, G. J. Martens, and F. W. Van Leeuwen (1998). Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: Indications for a processing defect. J. Clin. Endocrinol. Metab. 83:591-599.
87. Gabriels, R. L., M. L. Cuccaro, D. E. Hill, B. J. Ivers, and E. Goldson (2005). Repetitive behaviors in autism: Relationships with associated clinical features. Res. Dev. Disabil. 26:169-181.
88. Gaffney, G. R., L. Y. Tsai, S. Kuperman, and S. Minchin (1987). Cerebellar structure in autism. Am. J. Dis. Child 141:1330-1332.
89. Gainer, H., M. O. Lively, and M. Morris (1995). Immunological and related techniques for studying neurohypophyseal peptide-processing pathways. Methods Neurosci. 23:195-207.
90. Garber, H. J. and E. R. Ritvo (1992). Magnetic resonance imaging of the posterior fossa in autistic adults. Am. J. Psychiatry 149:245-247.
91. Gessaga, E. C. and H. Urich (1985). The cerebellum of epileptics. Clin. Neuropathol. 4:238-245.
92. Ghaziuddin, M., L. Y. Tsai, and N. Ghaziuddin (1992). Autism in Down’s syndrome: Presentation and diagnosis. J. Intellect. Disabil. Res. 36(Pt 5):449-456.
93. Gillberg, C. (1998). Chromosomal disorders and autism. J. Autism Dev. Disord. 28:415-425.
94. Gillberg C. and M. Coleman (1996). Autism and medical disorders: A review of the literature. Dev. Med. Child. Neurol. 38:191-202.
95. Gillberg, C. and L. de Souza (2002). Head circumference in autism, Asperger syndrome, and ADHD: A comparative study. Dev. Med. Child Neurol. 44:296-300.
96. Glabe, C. (2001). Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease. J. Mol. Neurosci. 17:137-145.
97. Green, L. A., D. Fein, C. Modahl, C. Feinstein, L. Waterhouse, and M. Morris (2001). Oxytocin and autistic disorder: Alteration in peptide forms. Biol. Psychiatry 50:609-613.
98. Grelotti, D., I. Gauthier, and R. T. Shultz (2001). Social interest and the development of cortical face specialization: What autism teaches us about face processing. Dev. Psychobiol. 40:213-225.
99. Griebel, G., J. Simiand, G. C. Serradeil-Le, J. Wagnon, M. Pascal, B. Scatton, J. P. Maffrand, and P. Soubrie (2002). Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc. Natl. Acad. Sci. USA 99:6370-6375.
100. Guerrini, R. and C. Marini (2006). Genetic malformations of cortical development. Exp. Brain Res. 173:322-333.
101. Hagerman, R. J. (2002). The physical and behavioral phenotype. In R. J. Hagerman and P. J. Hagerman (eds.), Fragile X Syndrome: Diagnosis, Treatment, and Research. Johns Hopkins University Press, Baltimore, MD, pp. 206-248.
102. Happe, F. (1999). Autism: Cognitive deficit or cognitive style? Trends Cogn. Sci. 3:216-222.
103. Happe, F., A. Ronald, and R. Plomin (2006). Time to give up on a single explanation for autism. Nat. Neurosci. 9:1218-1220.
104. Hardan, A. Y., N. J. Minshew, M. Mallikarjuhn, and M. S. Keshavan (2001). Brain volume in autism. J. Child Neurol. 16:421-424.
105. Hardiman, O., T. Burke, J. Phillips, S. Murphy, B. O’Moore, H. Staunton, and M. A. Farrell (1988). Microdysgenesis in resected temporal neocortex: Incidence and clinical significance in focal epilepsy. Neurology 38:1041-1047.
106. Harris, N. S., E. Courchesne, J. Townsend, R. A. Carper, and C. Lord (1999). Neuroanatomic contributions to slowed orienting of attention in children with autism. Brain Res. Cogn. Brain Res. 8:61-71.
107. Harris, S. R., L. L. MacKay, and J. A. Osborn (1995). Autistic behaviors in offspring of mothers abusing alcohol and other drugs: A series of case reports. Alcohol Clin. Exp. Res. 19:660-665.
108. Hashimoto, T., M. Tayama, M. Miyazaki, K. Murakawa, and Y. Kuroda (1993). Brainstem and cerebellar vermis involvement in autistic children. J. Child Neurol. 8:149-153.
109. Hashimoto, T., M. Tayama, M. Miyazaki, N. Sakurama, T. Yoshimoto, K. Murakawa, and Y. Kuroda (1992). Reduced brainstem size in children with autism. Brain Dev. 14:94-97.
110. Hashimoto, T., M. Tayama, K. Mori, K. Fujino, M. Miyazaki, and Y. Kuroda (1989). Magnetic resonance imaging in autism: Preliminary report. Neuropediatrics 20:142-146.
111. Hashimoto, T., M. Tayama, K. Murakawa, T. Yoshimoto, M. Miyazaki, M. Harada, and Y. Kuroda (1995). Development of the brainstem and cerebellum in autistic patients. J. Autism Dev. Disord. 25:1-18.
112. Hasselmo, M. E., E. T. Rolls, and G. C. Baylis (1989). The role of expression and identity in the face-selective responses of neurons in the temporal visual cortex of the monkey. Behav. Brain Res. 32:203-218.
113. Hazlett, H. C., M. Poe, G. Gerig, R. G. Smith, J. Provenzale, A. Ross, J. Gilmore, and J. Piven (2005). Magnetic resonance imaging and head circumference study of brain size in autism: Birth through age 2 years. Arch. Gen. Psychiatry 62:1366-1376.
114. Haznedar, M. M., M. S. Buchsbaum, M. Metzger, A. Solimando, J. Spiegel-Cohen, and E. Hollander (1997). Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am. J. Psychiatry 154:1047-1050.
115. Haznedar, M. M., M. S. Buchsbaum, T. C. Wei, P. R. Hof, C. Cartwright, C. A. Bienstock, and E. Hollander (2000). Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am. J. Psychiatry 157:1994-2001.
116. Herbert, M. R., G. J. Harris, K. T. Adrien, D. A. Ziegler, N. Makris, D. N. Kennedy, N. T. Lange, C. F. Chabris, A. Bakardjiev, J. Hodgson, M. Takeoka, H. Tager-Flusberg, and V. S. Caviness Jr. (2002). Abnormal asymmetry in language association cortex in autism. Ann. Neurol. 52:588-596.
117. Herbert, M. R., D. A. Ziegler, C. K. Deutsch, L. M. O’Brien, N. Lange, A. Bakardjiev, J. Hodgson, K. T. Adrien, S. Steele, N. Makris, D. Kennedy, G. J. Harris, and V. S. Caviness Jr. (2003). Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain 126:1182-1192.
118. Herbert, M. R., D. A. Ziegler, N. Makris, P. A. Filipek, T. L. Kemper, J. J. Normandin, H. A. Sanders, D. N. Kennedy, and V. S. Caviness Jr. (2004). Localization of white matter volume increase in autism and developmental language disorder. Ann. Neurol. 55:530-540.
119. Herken, H., E. Uz, H. Ozyurt, S. Sogut, O. Virit, and O. Akyol (2001). Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol. Psychiatry 6:66-73.
120. Hevner, R. F. (2007). Layer-specific markers as probes for neuron type identity in human neocortex and malformations of cortical development. J. Neuropathol. Exp. Neurol. 66:101-109.
121. Hollander, E., E. Anagnostou, W. Chaplin, K. Esposito, M. M. Haznedar, E. Licalzi, S. Wasserman, L. Soorya, and M. Buchsbaum (2005). Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol. Psychiatry 58:226-232.
122. Hollander, E., S. Novotny, M. Hanratty, R. Yaffe, C. M. DeCaria, B. R. Aronowitz, and S. Mosovich (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology 28:193-198.
123. Holttum, J. R., N. J. Minshew, R. S. Sanders, and N. E. Phillips (1992). Magnetic resonance imaging of the posterior fossa in autism. Biol. Psychiatry 32:1091-1101.
124. Howlin, P., L. Wing, and J. Gould. 1995. The recognition of autism in children with Down syndrome-Implications for intervention and some speculations about pathology. Dev. Med. Child Neurol. 37: 406-414.
125. Hoyer, D., D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R. Saxena, and P. P. Humphrey (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46:157-203.
126. Hsu, M., R. Yeung-Courchesne, E. Courchesne, and G. A. Press (1991). Absence of magnetic resonance imaging evidence of pontine abnormality in infantile autism. Arch. Neurol. 48:1160-1163.
127. Hudson, L. P., D. G. Munoz, L. Miller, R. S. McLachlan, J. P. Girvin, and W. T. Blume (1993). Amygdaloid sclerosis in temporal lobe epilepsy. Ann. Neurol. 33:622-631.
128. Jallon, P. (1997). Epilepsy and the heart. Rev. Neurol. 153:173-184.
129. Jellinger, K., D. Armstrong, H. Y. Zoghbi, and A. K. Percy (1988). Neuropathology of Rett syndrome. Acta Neuropathol. 76:142-158.
130. Johns, J. M., D. A. Lubin, J. A. Lieberman, and J. M. Lauder (2002). Developmental effects of prenatal cocaine exposure on 5-HT1A receptors in male and female rat offspring. Dev. Neurosci. 24:522-530.
131. Joseph, R. M. and J. Tanaka (2003). Holistic and part-based face recognition in children with autism. J. Child Psychol. Psychiatry 44:529-542.
132. Just, M. A., V. L. Cherkassky, T. A. Keller, and N. J. Minshew (2004). Cortical activation and synchronization during sentence comprehension in high-functioning autism: Evidence of underconnectivity. Brain 127:1811-1821.
133. Juurlink, B. H. and P. G. Paterson (1998). Review of oxidative stress in brain and spinal cord injury: Suggestions for pharmacological and nutritional management strategies. J. Spinal Cord. Med. 21:309-334.
134. Kanwisher, N., D. Stanley, and A. Harris (1999). The fusiform face area is selective for faces not animals. Neuroreport 10:183-187.
135. Katoh-Semba, R., I. K. Takeuchi, R. Semba, and K. Kato (1997). Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J. Neurochem. 69:34-42.
136. Kaufmann, W. E., K. L. Cooper, S. H. Mostofsky, G. T. Capone, W. R. Kates, C. J. Newschaffer, I. Bukelis, M. H. Stump, A. E. Jann, and D. C. Lanham (2003). Specificity of cerebellar vermian abnormalities in autism: A quantitative magnetic resonance imaging study. J. Child Neurol. 18:463-470.
137. Kawamoto, Y., S. Nakamura, S. Nakano, N. Oka, I. Akiguchi, and J. Kimura (1996). Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain. Neuroscience 74:1209-1226.
138. Kemper, T. L. and M. L. Bauman (1993). The contribution of neuropathologic studies to the understanding of autism. Neurol. Clin. 11:175-187.
139. Kent, L., J. Evans, M. Paul, and M. Sharp (1999). Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev. Med. Child Neurol. 41:153-158.
140. Kientz, M. A. and W. Dunn (1997). A comparison of the performance of children with and without autism on the sensory profile. Am. J. Occup. Ther. 51:530-537.
141. Kirsch, P., C. Esslinger, Q. Chen, D. Mier, S. Lis, S. Siddhanti, H. Gruppe, V. S. Mattay, B. Gallhofer, and A. Meyer-Lindenberg (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 25:11489-11493.
142. Kondoh, M., T. Shiga, and N. Okado (2004). Regulation of dendrite formation of Purkinje cells by serotonin through serotonin 1A and serotonin 2A receptors in culture. Neurosci. Res. 48:101-109.
143. Koshino, H., P. A. Carpenter, N. J. Minshew, V. L. Cherkassky, T. A. Keller, and M. A. Just (2005). Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage 24:810-821.
144. Kramer, K., E. C. Azmitia, and P. M. Whitaker-Azmitia (1994). In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Brain Res. Dev. Brain Res. 78:142-146.
145. Kuperman, S., J. Beeghly, T. Burns, and L. Tsai (1987). Association of serotonin concentration to behavior and IQ in autistic children. J. Autism Dev. Disord. 17:133-140.
146. Lainhart, J. E., J. Piven, M. Wzorek, R. Landa, S. L. Santangelo, H. Coon, and S. E. Folstein (1997). Macrocephaly in children and adults with autism. J. Am. Acad. Child Adolesc. Psychiatry 36:282-290.
147. Landgraf, R. and I. D. Neumann (2004). Vasopressin and oxytocin release within the brain: A dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 25:150-176.
148. Langen, M., S. Durston, W. G. Staal, S. J. Palmen, and H. van Engeland (2007). Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol. Psychiatry 62:262-266.
149. Lee, M., C. Martin-Ruiz, A. Graham, J. Court, E. Jaros, R. Perry, P. Iversen, M. Bauman, and E. Perry (2002). Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125:1483-1495.
150. Levitt, J. G., R. Blanton, L. Capetillo-Cunliffe, D. Guthrie, A. Toga, and J. T. McCracken (1999). Cerebellar vermis lobules VIII-X in autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 23:625-633.
151. Lidov, H. G. and M. E. Molliver (1982). Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res Bull. 9:559-604.
152. Lopez-Hurtado, E. and J. J. Prieto (2008). A microscopic study of language-related cortex in autism. Am. J. Biochem. Biotechnol. Special Issue on Autism Spectrum Disorders, 4:130-145.
153. Lord, C., S. Risi, L. Lambrecht, E. H. Cook Jr., B. L. Leventhal, P. C. DiLavore, A. Pickles, and M. Rutter (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Dev. Disord. 30:205-223.
154. Lord, C. and M. Rutter (1995). Autism and pervasive developmental disorders. In M. Rutter, E. Taylor, and L. Hersov (eds.), Child and Adolescent Psychiatry, Modern Approaches. Blackwell Science, Oxford, pp. 569-593.
155. Mackenzie, I. R., R. S. McLachlan, C. S. Kubu, and L. A. Miller (1996). Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques. Neurology 46:425-429.
156. Mackenzie, I. R. and L. A. Miller (1994). Senile plaques in temporal lobe epilepsy. Acta Neuropathol. 87:504-510.
157. Maeshima, T., F. Shutoh, S. Hamada, K. Senzaki, K. Hamaguchi-Hamada, R. Ito, and N. Okado (1998). Serotonin2A receptor-like immunoreactivity in rat cerebellar Purkinje cells. Neurosci. Lett. 252:72-74.
158. Manaye, K. F., D. L. Lei, Y. Tizabi, M. I. vila-Garcia, P. R. Mouton, and P. H. Kelly (2005). Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder. J. Neuropathol. Exp. Neurol. 64:224-229.
159. Martin, G. R. and P. P. Humphrey (1994). Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 33:261-273.
160. Mason-Brothers, A., E. R. Ritvo, C. Pingree, P. B. Petersen, W. R. Jenson, W. M. McMahon, B. J. Freeman, L. B. Jorde, M. J. Spencer, and A. Mo (1990). The UCLA-University of Utah epidemiologic survey of autism: Prenatal, perinatal, and postnatal factors. Pediatrics 86:514-519.
161. McClelland, J. L. (2000). The basis of hyperspecificity in autism: A preliminary suggestion based on properties of neural nets. J. Autism Dev. Disord. 30:497-502.
162. Mendez, M. F., N. L. Adams, and K. S. Lewandowski (1989). Neurobehavioral changes associated with caudate lesions. Neurology 39:349-354.
163. Menendez, M. (2005). Down syndrome, Alzheimer’s disease and seizures. Brain Dev 27:246-252.
164. Miles, J. H., L. L. Hadden, T. N. Takahashi, and R. E. Hillman (2000). Head circumference is an independent clinical finding associated with autism. Am. J. Med. Genet. 95:339-350.
165. Miles, J. H., T. N. Takahashi, S. Bagby, P. K. Sahota, D. F. Vaslow, C. H. Wang, R. E. Hillman, and J. E. Farmer (2005). Essential versus complex autism: Definition of fundamental prognostic subtypes. Am. J. Med. Genet. A 135:171-180.
166. Ming, X., T. P. Stein, M. Brimacombe, W. G. Johnson, G. H. Lambert, and G. C. Wagner (2005). Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot. Essent. Fatty Acids 73:379-384.
167. Mitchell, B. F., X. Fang, and S. Wong (1998). Role of carboxy-extended forms of oxytocin in the rat uterus in the process of parturition. Biol. Reprod. 59:1321-1327.
168. Miyazaki, K., N. Narita, R. Sakuta, T. Miyahara, H. Naruse, N. Okado, and M. Narita (2004). Serum neurotrophin concentrations in autism and mental retardation: A pilot study. Brain Dev. 26:292-295.
169. Muhle, R., S. V. Trentacoste, and I. Rapin (2004). The genetics of autism. Pediatrics 113:e472-e486.
170. Muller, R. A. (2007). The study of autism as a distributed disorder. Ment. Retard. Dev. Disabil. Res. Rev. 13:85-95.
171. Murakami, J. W., E. Courchesne, G. A. Press, R. Yeung-Courchesne, and J. R. Hesselink (1989). Reduced cerebellar hemisphere size and its relationship to vermal hypoplasia in autism. Arch. Neurol. 46:689-694.
172. Murer, M. G., Q. Yan, and R. Raisman-Vozari (2001). Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog. Neurobiol. 63:71-124.
173. Narita, N., M. Kato, M. Tazoe, K. Miyazaki, M. Narita, and N. Okado (2002). Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acidexposed rat: Putative animal models for autism. Pediatr. Res. 52:576-579.
174. Nashef, L., F. Walker, P. Allen, J. W. Sander, S. D. Shorvon, and D. R. Fish (1996). Apnoea and bradycardia during epileptic seizures: Relation to sudden death in epilepsy. J. Neurol. Neurosurg. Psychiatry 60:297-300.
175. Nawa, H., J. Carnahan, and C. Gall (1995). BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: Partial disagreement with mRNA levels. Eur. J. Neurosci. 7:1527-1535.
176. Nelson, E. and J. Panksepp (1996). Oxytocin mediates acquisition of maternally associated odor preferences in preweanling rat pups. Behav. Neurosci. 110:583-592.
177. Newschaffer, C. J., D. Fallin, and N. L. Lee (2002). Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiol. Rev. 24:137-153.
178. Niitsu, Y., S. Hamada, K. Hamaguchi, M. Mikuni, and N. Okado (1995). Regulation of synapse density by 5-HT2A receptor agonist and antagonist in the spinal cord of chicken embryo. Neurosci. Lett. 195:159-162.
179. Nishizawa, S., C. Benkelfat, S. N. Young, M. Leyton, S. Mzengeza, M. C. de, P. Blier, and M. Diksic (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. USA. 94:5308-5313.
180. Okado, N., L. Cheng, Y. Tanatsugu, S. Hamada, and K. Hamaguchi (1993). Synaptic loss following removal of serotoninergic fibers in newly hatched and adult chickens. J. Neurobiol. 24:687-698.
181. Ono, H., A. Sakamoto, and N. Sakura (2001). Plasma total glutathione concentrations in healthy pediatric and adult subjects. Clin. Chim. Acta 312:227-229.
182. Oppenheim, R. W. (1991). Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:453-501.
183. Palmen, S. J., H. van Engeland, P. R. Hof, and C. Schmitz (2004). Neuropathological findings in autism. Brain 127:2572-2583.
184. Pennington, B. F., P. A. Filipek, D. Lefly, N. Chhabildas, D. N. Kennedy, J. H. Simon, C. M. Filley, A. Galaburda, and J. C. DeFries (2000). A twin MRI study of size variations in human brain. J. Cogn. Neurosci. 12:223-232.
185. Perrett, D. I., P. A. Smith, D. D. Potter, A. J. Mistlin, A. S. Head, A. D. Milner, and M. A. Jeeves (1985). Visual cells in the temporal cortex sensitive to face view and gaze direction. Proc. R. Soc. Lond B Biol. Sci. 223:293-317.
186. Perry, E. K., M. L. Lee, C. M. Martin-Ruiz, J. A. Court S. G. Volsen, J. Merrit, E. Folly, P. E. Iversen, M. L. Bauman, R. H. Perry, and G. L. Wenk (2001). Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry 158:1058-1066.
187. Perry, S. W., J. P. Norman, A. Litzburg, and H. A. Gelbard (2004). Antioxidants are required during the early critical period, but not later, for neuronal survival. J. Neurosci. Res. 78:485-492.
188. Pfefferbaum, A., E. V. Sullivan, G. E. Swan, and D. Carmelli (2000). Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiol. Aging 21:63-74.
189. Pickett, J. and E. London (2005). The neuropathology of autism: A review. J. Neuropathol. Exp. Neurol. 64:925-935.
190. Pierce, K. and E. Courchesne (2001). Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol. Psychiatry 49:655-664.
191. Pierce, K., R. A. Muller, J. Ambrose, G. Allen, and E. Courchesne (2001). Face processing occurs outside the fusiform “face area” in autism: Evidence from functional MRI. Brain 124:2059-2073.
192. Pierce, K., F. Haist, F. Sedaghat, and E. Courchesne (2004). The brain response to personally familiar faces in autism: Findings of fusiform activity and beyond. Brain 127:2703-2716.
193. Piven, J., E. Nehme, J. Simon, P. Barta, G. Pearlson, and S. E. Folstein (1992). Magnetic resonance imaging in autism: Measurement of the cerebellum, pons, and fourth ventricle. Biol. Psychiatry 31:491-504.
194. Piven, J., S. Arndt, J. Bailey, S. Havercamp, N. C. Andreasen, and P. Palmer (1995). An MRI study of brain size in autism. Am. J. Psychiatry 152:1145-1149.
195. Piven, J., S. Arndt, J. Bailey, and N. Andreasen (1996). Regional brain enlargement in autism: A magnetic resonance imaging study. J. Am. Acad. Child Adolesc. Psychiatry 35:530-536.
196. Piven, J., K. Saliba, J. Bailey, and S. Arndt (1997a). An MRI study of autism: The cerebellum revisited. Neurology 49:546-551.
197. Piven, J., J. Bailey, B. J. Ranson, and S. Arndt (1997b). An MRI study of the corpus callosum in autism. Am. J. Psychiatry 154:1051-1056.
198. Piven, J., J. Bailey, B. J. Ranson, and S. Arndt (1998). No difference in hippocampus volume detected on magnetic resonance imaging in autistic individuals. J. Autism Dev. Disord. 28:105-110.
199. Poldrack, R. A., V. Prabhakaran, C. A. Seger, and J. D. Gabrieli (1999). Striatal activation during acquisition of a cognitive skill. Neuropsychology 13:564-574.
200. Popik, P. and J. M. Van Ree (1992). Long-term facilitation of social recognition in rats by vasopressin related peptides: A structure-activity study. Life Sci. 50:567-572.
201. Popik, P., J. Vetulani, and J. M. Van Ree (1992). Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology 106:71-74.
202. Prasher, V. P. and D. J. Clarke (1996). Case report: Challenging behaviour in a young adult with Down’s syndrome and autism. Brit. J. Learning Disab. 24:167-169.
203. Raggenbass, M. 2001. Vasopressin- and oxytocin-induced activity in the central nervous system: Electrophysiological studies using in-vitro systems. Prog. Neurobiol. 64:307-326.
204. Rao, V. V., C. Loffler, J. Battey, and I. Hansmann (1992). The human gene for oxytocinneurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet. Cell Genet. 61:271-273.
205. Rapin, I. (1996). Preschool Children with Inadequate Communication: Developmental Language Disorder, Autism, Low IQ. MacKeith Press, London.
206. Rathbun, W. and M. J. Druse (1985). Dopamine, serotonin, and acid metabolites in brain regions from the developing offspring of ethanol-treated rats. J. Neurochem. 44:57-62.
207. Redcay, E. and E. Courchesne. (2005). When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol. Psychiatry 58:1-9.
208. Reeves, A. L., K. E. Nollet, D. W. Klass, F. W. Sharbrough, and E. L. So (1996). The ictal bradycardia syndrome. Epilepsia 37:983-987.
209. Risse, S. C., T. H. Lampe, T. D. Bird, D. Nochlin, S. M. Sumi, T. Keenan, L. Cubberley, E. Peskind, and M. A. Raskind (1990). Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 4:217-225.
210. Ritvo, E. R., B. J. Freeman, A. B. Scheibel, T. Duong, H. Robinson, D. Guthrie, and A. Ritvo (1986). Lower Purkinje cell counts in the cerebella of four autistic subjects: Initial findings of the UCLA-NSAC Autopsy Research Report. Am. J. Psychiatry 143:862-866.
211. Rodier, P. M., J. L. Ingram, B. Tisdale, S. Nelson, and J. Romano (1996). Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370:247-261.
212. Rogers, S. J., L. Bennetto, R. McEvoy, and B. F. Pennington (1996). Imitation and pantomime in high-functioning adolescents with autism spectrum disorders. Child Dev. 67:2060-2073.
213. Roth, B. L. (1994). Multiple serotonin receptors: Clinical and experimental aspects. Ann. Clin. Psychiatry 6:67-78.
214. Rutter, M., A. Bailey, P. Bolton, and C. A. Le (1994). Autism and known medical conditions: Myth and substance. J. Child Psychol. Psychiatry 35:311-322.
215. Saitoh, O. and E. Courchesne (1998). Magnetic resonance imaging study of the brain in autism. Psychiatry Clin. Neurosci. 52 Suppl:S219-S222.
216. Sajdel-Sulkowska, E. M., B. Lipinski, H. Windom, T. Audhya, and W. McGinnis (2008). Oxidative stress in autism: Cerebellar 3-nitrotyrosine levels. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:73-84.
217. Sarnat, H. B. and L. Flores-Sarnat (2004). Integrative classification of morphology and molecular genetics in central nervous system malformations. Am. J. Med. Genet. A 126A:386-392.
218. Saudou, F. and R. Hen (1994a). 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem. Int. 25:503-532.
219. Saudou, F. and R. Hen (1994b). 5-Hydroxytryptamine receptor subtypes: Molecular and functional diversity. Adv. Pharmacol. 30:327-380.
220. Saussu, F., K. van Rijckevorsel, and T. de Barsy (1998). Bradycardia: An unrecognized complication of some epileptic crises. Rev Neurol. 154:250-252.
221. Schaefer, G. B., J. N. Thompson, J. B. Bodensteiner, J. M. McConnell, W. J. Kimberling, C. T. Gay, W. D. Dutton, D. C. Hutchings, and S. B. Gray (1996). Hypoplasia of the cerebellar vermis in neurogenetic syndromes. Ann. Neurol. 39:382-385.
222. Schmidt-Kastner, R., C. Wetmore, and L. Olson (1996). Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex. Neuroscience 74:161-183.
223. Schmidtke, K., H. Manner, R. Kaufmann, and H. Schmolck (2002). Cognitive procedural learning in patients with fronto-striatal lesions. Learn. Mem. 9:419-429.
224. Schultz, R. T. (2005). Developmental deficits in social perception in autism: The role of the amygdala and fusiform face area. Int. J. Dev. Neurosci. 23:125-141.
225. Sears, L. L., C. Vest, S. Mohamed, J. Bailey, B. J. Ranson, and J. Piven (1999). An MRI study of the basal ganglia in autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 23:613-624.
226. Shapiro, L. E. and T. R. Insel (1989). Ontogeny of oxytocin receptors in rat forebrain: A quantitative study. Synapse 4:259-266.
227. Sheng, J. G., F. A. Boop, R. E. Mrak, and W. S. Griffin (1994). Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1 alpha immunoreactivity. J. Neurochem. 63:1872-1879.
228. Shulman, R. G., D. L. Rothman, K. L. Behar, and F. Hyder (2004). Energetic basis of brain activity: Implications for neuroimaging. Trends Neurosci. 27:489-495.
229. Siegel, D. J., N. J. Minshew, and G. Goldstein (1996). Wechsler IQ profiles in diagnosis of high-functioning autism. J. Autism Dev. Disord. 26:389-406.
230. Smalley, S. L., R. F. Asarnow, and M. A. Spence (1988). Autism and genetics. A decade of research. Arch. Gen. Psychiatry 45:953-961.
231. Sohal, R. S. and U. T. Brunk (1989). Lipofuscin as an indicator of oxidative stress and aging. Adv. Exp. Med. Biol. 266:17-26.
232. Sokol, D. K., D. Chen, M. R. Farlow, D. W. Dunn, B. Maloney, J. A. Zimmer, and D. K. Lahiri (2006). High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J. Child Neurol. 21:444-449.
233. Sparks, B. F., S. D. Friedman, D. W. Shaw, E. H. Aylward, D. Echelard, A. A. Artru, K. R. Maravilla, J. N. Giedd, J. Munson, G. Dawson, and S. R. Dager (2002). Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59:184-192.
234. Stefanacci, L. and D. G. Amaral (2000). Topographic organization of cortical inputs to the lateral nucleus of the macaque monkey amygdala: A retrograde tracing study. J. Comp. Neurol. 421:52-79.
235. Steg, J. P. and J. L. Rapoport (1975). Minor physical anomalies in normal, neurotic, learning disabled, and severely disturbed children. J. Autism Child Schizophr. 5:299-307.
236. Stevenson, R. E., R. J. Schroer, C. Skinner, D. Fender, and R. J. Simensen (1997). Autism and macrocephaly. Lancet 349:1744-1745.
237. Stojanovic, A., A. E. Roher, and M. J. Ball (1994). Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brains. Dementia 5:229-233.
238. Stone, W. L., O. Y. Ousley, P. J. Yoder, K. L. Hogan, and S. L. Hepburn (1997). Nonverbal communication in two- and three-year-old children with autism. J. Autism Dev. Disord. 27:677-696.
239. Stromland, K., V. Nordin, M. Miller, B. Akerstrom, and C. Gillberg (1994). Autism in thalidomide embryopathy: A population study. Dev. Med. Child Neurol. 36:351-356.
240. Sutcliffe, J. S., R. J. Delahanty, H. C. Prasad, J. L. McCauley, Q. Han, L. Jiang, C. Li, S. E. Folstein, and R. D. Blakely (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 77:265-279.
241. Sutula, T. P. and A. Pitkanen (2001). More evidence for seizure-induced neuron loss: Is hippocampal sclerosis both cause and effect of epilepsy? Neurology 57:169-170.
242. Swaab, D. F. (1997). Prader-Willi syndrome and the hypothalamus. Acta Paediatr. Suppl. 423:50-54.
243. Szatmari, P., M. B. Jones, L. Zwaigenbaum, and J. E. MacLean (1998). Genetics of autism: Overview and new directions. J. Autism Dev. Disord. 28:351-368.
244. Szweda, P. A., M. Camouse, K. C. Lundberg, T. D. Oberley, and L. I. Szweda (2003). Aging, lipofuscin formation, and free radical-mediated inhibition of cellular proteolytic systems. Ageing Res. Rev. 2:383-405.
245. Tapia-Arancibia, L., F. Rage, L. Givalois, and S. Arancibia (2004). Physiology of BDNF: Focus on hypothalamic function. Front. Neuroendocrinol. 25:77-107.
246. Tasch, E., F. Cendes, L. M. Li, F. Dubeau, F. Andermann, and D. L. Arnold (1999). Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann. Neurol. 45:568-576.
247. Terman, A. and U. T. Brunk (2004). Lipofuscin. Int. J. Biochem. Cell Biol. 36:1400-1404.
248. Thom, M., B. Griffin, J. W. Sander, and F. Scaravilli (1999). Amygdala sclerosis in sudden and unexpected death in epilepsy. Epilepsy Res. 37:53-62.
249. Torsdottir, G., J. Kristinsson, S. Sveinbjornsdottir, J. Snaedal, and T. Johannesson (1999). Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson’s disease. Pharmacol. Toxicol. 85:239-243.
250. Townsend, J., E. Courchesne, J. Covington, M. Westerfield, N. S. Harris, P. Lyden, T. P. Lowry, and G. A. Press (1999). Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J. Neurosci. 19:5632-5643.
251. Tuchman, R. F., I. Rapin, and S. Shinner (1991). Autistic and dysphasic children II: Epilepsy. Pediatrics 88:1219-1225.
252. Tuchman, R. F. and I. Rapin (2002). Epilepsy in autism. Lancet Neurol. 1:352-358.
253. van Kooten, I., S. J. Palmen, P. von Cappeln, H. W. Steinbusch, H. Korr, H. Heinsen, P. R. Hof, H. van Engeland, and C. Schmitz (2008). Neurons in the fusiform gyrus are fewer and smaller in autism. Brain 131:987-999.
254. Velez, L. and L. M. Selwa (2003). Seizure disorders in the elderly. Am. Fam. Physician 67:325-332.
255. Voelbel, G. T., M. E. Bates, J. F. Buckman, G. Pandina, and R. L. Hendren (2006). Caudate nucleus volume and cognitive performance: Are they related in childhood psychopathology? Biol. Psychiatry 60:942-950.
256. Volkmar, F. R., A. Carter, S. S. Sparrow, and D. V. Cicchetti (1993). Quantifying social development in autism. J. Am. Acad. Child Adolesc. Psychiatry 32:627-632.
257. Vorstman, J. A. S., W. G. Staal, E. van Daalen, H. van Engeland, P. F. R. Hochstenbach, and L. Franke (2006). Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol. Psych. 11:18-28.
258. Waiter, G. D., J. H. Williams, A. D. Murray, A. Gilchrist, D. I. Perrett, and A. Whiten (2004). A voxel-based investigation of brain structure in male adolescents with autistic spectrum disorder. Neuroimage 22:619-625.
259. Wakabayashi, S. (1979). A case of infantile autism associated with Down’s syndrome. J. Autism Dev. Disord. 9:31-36.
260. Wegiel, J., I. Kuchna, K. Nowicki, J. Frackowiak, B. Mazur-Kolecka, H. Imaki, J. Wegiel, P. D. Mehta, W. P. Silverman, B. Reisberg, M. Deleon, T. Wisniewski, T. Pirttilla, H. Frey, T. Lehtimaki, T. Kivimaki, F. E. Visser, W. Kamphorst, A. Potempska, D. Bolton, J. R. Currie, and D. L. Miller (2007). Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathol. 113:389-402.
261. Wegiel, J., E. London, I. L. Cohen, M. Flory, T. Wisniewski, H. Imaki, I. Kuchna, J. Wegiel, S. Y. Ma, K. Nowicki, J. Wang, and W. T. Brown (2008). Detection of leading developmental defects in brains of autistic subjects. In 7th Annual International Meeting for Autism Research (IMFAR) London, U.K.
262. Wetherby, A. M., B. M. Prizant, and T. Hutchinson (1998). Communicative, social-affective, and symbolic profiles of young children with autism and pervasive developmental disorder. Am. J. Speech Language Pathol. 7:79-91.
263. Whitaker-Azmitia, P. M. (2005). Behavioral and cellular consequences of increasing serotonergic activity during brain development: A role in autism? Int. J. Dev. Neurosci. 23:75-83.
264. Williams, J. H., A. Whiten, T. Suddendorf, and D. I. Perrett (2001). Imitation, mirror neurons and autism. Neurosci. Biobehav. Rev. 25:287-295.
265. Windle, R. J., N. Shanks, S. L. Lightman, and C. D. Ingram (1997). Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138:2829-2834.
266. Wu, S. P., M. X. Jia, Y. Ruan, Y. Q. Guo, M. Shuang, X. H. Gong, Y. B. Zhang, X. L. Yang, and D. Zhang (2005). Positive association of the oxytocine receptor gene (OXTR) with autism in the Chinese Han population. Biol. Psychiatry 58:74-77.
267. Yan, Q., R. D. Rosenfeld, C. R. Matheson, N. Hawkins, O. T. Lopez, L. Bennett, and A. A. Welcher (1997). Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 78:431-448.
268. Yanik, M., H. Vural, H. Tutkun, S. S. Zoroglu, H. A. Savas, H. Herken, A. Kocyigit, H. Keles, and O. Akyol (2004). The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur. Arch. Psychiatry Clin. Neurosci. 254:43-47.
269. Yip, J., J. J. Soghomonian, and G. J. Blatt (2007). Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: Pathophysiological implications. Acta Neuropathol. 113:559-568.
270. Yip, J., J. J. Soghomonian, and G. J. Blatt (2008). Increased GAD67 mRNA expression in cerebellar interneurons in autism: Implications for Purkinje cell dysfunction. J. Neurosci. Res. 86:525-530.
271. Yonan, A. L., M. Alarcon, R. Cheng, P. K. Magnusson, S. J. Spence, A. A. Palmer, A. Grunn, S. H. Juo, J. D. Terwilliger, J. Liu, R. M. Cantor, D. H. Geschwind, and T. C. Gilliam (2003). A genomewide screen of 345 families for autism-susceptibility loci. Am. J. Hum. Genet. 73:886-897.
272. Zilbovicius, M., B. Garreau, Y. Samson, P. Remy, C. Barthelemy, A. Syrota, and G. Lelord (1995). Delayed maturation of the frontal cortex in childhood autism. Am. J. Psychiatry 152:248-252.
273. Zoroglu, S. S., F. Armutcu, S. Ozen, A. Gurel, E. Sivasli, O. Yetkin, and I. Meram (2004). Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur. Arch. Psychiatry Clin. Neurosci. 254:143-147.